You are here: Home / Events / RCMI Events / The Paths to Approvals of Therapeutics and Diagnostics at the FDA in the Era of Personalized Medicine and the 21st Century Cures Legislation

The Paths to Approvals of Therapeutics and Diagnostics at the FDA in the Era of Personalized Medicine and the 21st Century Cures Legislation

When Jan 31, 2017
from 12:00 PM to 01:00 PM
Where 6th floor Amphitheater, UPR-MSC Main Building, UPR-Medical Sciences Campus
Add event to calendar vCal
iCal

by

Federico Goodsaid, Ph.D.

Vice President of Assay Development and Regulatory Affairs
TOMA Biosciences, Foster City, CA

This seminar series is supported by an NIGMS INBRE grant P20 GM103475 in collaboration with UPR-SOM Biomedical Sciences Graduate Program, Puerto Rico Clinical and Translational Research Consortium TRCL (U54 MD007587) and RCMI CGHDRD (G12 MD007600).

Navigation
Our YouTube Channel

YouTube logo

ZIKA INITIATIVE

RTRN

WebNews

Web News Sept 2011

Our monthly newsletter.
Contact us!
Emma Fernández-Repollet,Ph.D.
Principal Investigator
RCMI Program
Room 621-A, 6th floor
Guillermo Arbona Building
Medical Sciences Campus
GPO Box 365067
San Juan, PR 00936-5067
Voice (787) 763-9401
FAX (787) 758-5206
UPR

Acknowledgement of Funding

This program is funded by RCMI grant G12 MD007600 (National Institute on Minority Health and Health Disparities) from the National Institutes of Health.  Please use this number to acknowledge support.

« March 2017 »
March
SuMoTuWeThFrSa
1234
567891011
12131415161718
19202122232425
262728293031
NIMHD